Brigit Riley
Plus aucun poste en cours
Fortune : 157 576 $ au 31/03/2024
Profil
Brigit Riley worked as Vice President at Sangamo Therapeutics, Inc. from 2014 to 2019 and as Chief Scientific Officer at Adverum Biotechnologies, Inc. from 2021 to 2024.
She completed her undergraduate degree at Northwestern University and her doctorate at the University of Minnesota.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2023 | 11 144 ( 0,05% ) | 157 576 $ | 31/03/2024 |
Anciens postes connus de Brigit Riley
| Sociétés | Poste | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 29/01/2024 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
Formation de Brigit Riley
| Northwestern University | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
